Press Releases
2007
| Nov-28-07 | Cortex’s CEO Roger Stoll to Speak at the Bank of Montreal’s Focus on Healthcare Conference |
| Nov-8-07 | Cortex Reports Third Quarter Operating Results |
| Nov-1-07 | Cortex’s CEO to Present at Rodman & Renshaw’s Ninth Annual Healthcare Conference On November 5, 2007 |
| Oct-26-07 | Cortex to Provide Shareholder Update and Host Conference Call on October 31, 2007 |
| Oct-16-07 | Cortex Names Pierre V. Trân, MD, MMM, Chief Medical Officer and Vice President of Clinical Development |
| Oct-11-07 | FDA’s Psychiatric Division has Rejected Cortex’s Request to Study CX717 in Phase IIb ADHD Study |
| Sept-17-07 | Cortex to Provide Shareholder Update and Host Conference Call on September 19, 2007 |
| Sept-12-07 | Cortex Files Ampakine CX717 IND for ADHD |
| Sept-5-07 | Cortex’s CEO Roger Stoll to Speak at the Bear Stearns 20th Annual Healthcare Conference, New York, on September 10th, 2007 |
| Aug-30-07 | Cortex’s CEO Roger Stoll to Speak at the Roth Capital Partners New York Conference on September 5, 2007 |
| Aug-30-07 | Cortex Completes $14.2 Million Registered Direct Offering |
| Aug-24-07 | Cortex to Raise $14.2 Million in Registered Direct Offering |
| Aug-9-07 | Cortex Reports Second Quarter Operating Results |
| July-17-07 | Cortex to Resume Clinical Trial with AMPAKINE® CX717 in Alzheimer-PET Scan Study After FDA Approves Protocol with Higher Doses of Drug |
| June-07-07 | Cortex and the University of California, Irvine Extend Exclusive Licensing Agreement |
| May-16-07 | Cortex's CEO to Present at the JMP Securities Research Conference and Cortex's COO to Present at the Neurotech Industry Investing & Partnering Conference |
| May-10-07 | Cortex and The University of Alberta complete patent license agreement |
| May-10-07 | Cortex Reports First Quarter Operating Results |
| May-4-07 | Cortex Annual Shareholder Meeting Notification |
| Apr-18-07 | Cortex’s AMPAKINE CX717 Toxicology Data Package Submitted To FDA |
| Mar-15-07 | Cortex Reports Fourth Quarter and Year End Operating Results |
| Mar-12-07 | Cortex has licensed its AMPAKINE technology to Organon BioSciences N.V. Schering-Plough Corporation will acquire Organon BioSciences |
| Mar-6-07 | Cortex Pharmaceuticals Appoints Les Street, Ph.D., Head of Medicinal Chemistry and Steven A. Johnson, Ph.D., VP of Pre-Clinical Development Becomes an Officer of Cortex |
| Feb-23-07 | Update On Cortex’s CEO Presentation At The Roth Capital Partners 19th Annual Conference |
| Feb-13-07 | Cortex’s CEO To Present At The Roth Capital Partners 19th Annual Orange County Conference |
| Jan-23-07 | Cortex Completes $5.6 Million Direct Equity Placement |
| Jan-17-07 | Cortex To Raise $5.6 Million in Direct Equity Placement |
 |